OFFICIAL
1 No maternal health without mental health: suggested
2 indicators to monitor perinatal mental health globally
3
4 Francesca Palestra1*, #a, Allisyn C. Moran 1, #a, Neerja Chowdhary 2, #a, Tatiana Taylor Salisbury 3, Tarun
5 Dua 2&,#a, Shanon McNab 4&, Elly Layton5&, Elissa C Kennedy5&, Caroline SE Homer5&, Jane Fisher 6&,
6 Simone Honickman 7&, Zelee Hill8&.
7
8 1. Department of Maternal Newborn Child and Adolescent Health and Ageing (MCA), World
9 Health Organization (WHO), Geneva, Switzerland
10 2. Department of Mental Health, Brain Health and Substance Use (MSD), World Health
11 Organization (WHO), Geneva, Switzerland
12 3. Centre for Global Mental Health, King's College London, London, United Kingdom
13
14 4. MOMENTUM Country and Global Leadership, Jhpiego, Washington, District of Columbia,
15 United States of America
16 5. Burnet Institute, Australia
17 6. Public Health and Preventive Medicine, Monash University, Melbourne Australia
18
19 7. Department of psychiatry and mental health, University of Cape Town, Cape Town, South Africa
20 8. Institute for Global Health, University College London, London, United Kingdom
21
22 #a current address: Avenue Appia, Geneva Switzerland
23 *Corresponding author: Francesca Palestra,
[email protected]
24 FP is the senior author who wrote and conceived the paper
25 AM, NC and TTS are joint senior authors and supported in the process and development of the paper
26 & contributed equally to this work.
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
OFFICIAL
27 Abstract
28 Perinatal mental health refers to the psychological wellbeing of women during pregnancy and up to one
29 year postpartum. Perinatal mental health conditions as depression significantly affect maternal, newborn
30 health, and child development worldwide. However, the absence of standardized indicators limits
31 effective monitoring and evaluation. This paper introduces a framework with indicators for global
32 perinatal mental health monitoring.
33 The framework development involved a scoping review, expert consultations, and stakeholder surveys. A
34 global expert group, guided by evidence and the World Health Organization (WHO), identified an initial
35 set of indicators. Two rounds of online surveys were conducted, allowing stakeholders to rank these
36 indicators and suggest additional ones. Indicators were chosen based on their validity, reliability,
37 relevance, feasibility, and potential impact for advocacy purposes on perinatal mental health. The WHO
38 expert working group finalized the set of indicators.
39 Six perinatal mental health indicators were identified for future testing. These include three primary
40 indicators: policy presence, screening coverage, and prevalence of perinatal mental health conditions.
41 Three secondary indicators cover mental health expenditure, healthcare professional training, and
42 provision of care.
43 Challenges to implementing standardized monitoring include resource limitations and data collection
44 methods. Strengthening health workers and facility capacity to measure, report, and interpret perinatal
45 mental health data, including the use of screening tools, is crucial. The integration of these indicators into
46 existing systems, such as health information management systems (HIMS) and national surveys, will be
47 key.
48 Monitoring perinatal mental health is essential for improving maternal and newborn outcomes. The
49 proposed framework offers a means to enhance global monitoring and guide policy interventions. Global
50 stakeholders are encouraged to integrate perinatal mental health into their policy, program, and
51 monitoring agendas.
52
53 Key words
54 Perinatal mental health, maternal health, newborn health, depression, mental health conditions, health
55 monitoring, indicators
56
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
57 Introduction
58 Perinatal mental health (PMH) is one of the most neglected issues in maternal health [1]. PMH refers to
59 the psychological wellbeing of individuals during pregnancy and up to one year postpartum [2]. This is
60 not to be confused with the perinatal period of a newborn which is seven days after birth [3].
61 A variety of mental health conditions may be experienced during the perinatal period, including but not
62 limited to depression, anxiety, psychoses and alcohol and substance use [4, 5]. Perinatal mental health
63 conditions pose a significant burden globally, affecting millions of women each year. Globally it is
64 estimated that 10-20 % of pregnant women and those who just have given birth experience depression and
65 rates are highest in low- and middle-income countries [8, 9], Different cultural practices, poverty, biological
66 and social factors have been associated with influencing women’s vulnerability to perinatal mental health
67 conditions [10].
68 Poor PMH not only has adverse effects on the woman's quality of life but also impacts the health
69 outcomes of newborns and children [11]. For example, perinatal depression has been linked to suicide and
70 adverse birth outcomes, such as preterm birth and low birth weight, as well as long-term developmental
71 and behavioral issues in children [12, 13]. Perinatal mental health is therefore crucial for the wellbeing of
72 women and their babies.
73 Despite the prevalence and impact of perinatal mental health conditions, there is a lack of standardized
74 indicators for global monitoring. No perinatal mental health indicators are currently tracked routinely
75 across countries in health information management systems (HIMS) or through standardized national
76 health surveys as Demographic and Health Surveys (DHS) or Multiple Indicator Cluster Surveys MICS).
77 Existing indicators, mainly from high-income countries, vary widely between countries and regions,
78 making it challenging to compare data and assess the effectiveness of interventions [14, 15, 16].
79 Moreover, many indicators focus predominantly on the diagnosis and treatment of perinatal mental health
80 conditions (mainly postpartum depression) rather than on the services provided and the access of women
81 to those services, ensuring preventive measures and appropriate referral. There is also a need for more
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
82 comprehensive and integrated approaches to perinatal mental health monitoring that address the
83 complexity of healthcare systems and policies across countries ensuring integration across levels of care
84 and within maternal, newborn and child health services [17]. Standardized indicators are essential for
85 assessing the burden of perinatal mental health conditions globally and should show progress to address
86 perinatal mental health issues, as well as guide policy and resource allocation.
87
88 Overview of the Global PMH Theory of Change and scoping review on PMH
89 indicators
90 A Global PMH Theory of Change (ToC) was published in 2022 [18] providing a strategic roadmap for
91 developing standardized indicators for perinatal mental health monitoring. It outlines the underlying
92 assumptions and pathways through which the proposed indicators are expected to bring about positive
93 changes in the monitoring and management of perinatal mental health conditions. By identifying key
94 inputs, activities, outputs, outcomes, and impacts, the ToC serves as a guide for understanding how the
95 proposed indicators can contribute to improved maternal and newborn health outcomes. The ToC is based
96 on a social ecological model where its domains are in order: individual, interpersonal relationship,
97 community, service delivery ecosystem and policy landscape.
98 Further a scoping review conducted in 2023 aimed to identify existing perinatal mental health indicators
99 used in monitoring systems worldwide [17]. The search in the scoping review was conducted in accordance
100 with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping
101 Reviews. After consultation with WHO it was decided to exclude indicators related to risk factors for PMH
102 or did not measure PMH directly. Additional indicators which measured mental health but were not specific
103 to the perinatal period were excluded, as these are well described in WHO Mental Health Atlas [19]. Results
104 were compiled and mapped to the relevant level in the Global PMH ToC. The review considered the
105 indicators which: (1) aligned with the Global PMH ToC and landscape analysis definition of perinatal
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
106 mental health (during pregnancy and up to one year after childbirth); (2) had a definition, including how it
107 could be measured; and (3) was published from 1 January 2000 to 6 September 2023.
108 Nine indicators were identified which addressed individual (six indicators) and service-level (three
109 indicators) characteristics (Table 1). In order to be reflective of global differences in the feasibility and
110 availability of data to determine if indicators are met, stakeholder engagement in determining a final set
111 of indicators is needed.
112 Table 1. List of PMH indicators identified in the scoping review
Theory of change domain Indicator
Individual 1. Proportion of women with postpartum depression
Individual 2. Proportion of women with depression in perinatal period
Individual 3. Proportion of women with postpartum psychosis
Individual 4. Proportion of women with adjustment and distress in perinatal
period
Individual 5. Proportion of women with PTSD in perinatal period
Individual 6. Proportion of women with mental health conditions in perinatal
period
Service delivery ecosystem 7. Proportion of women screened for mental health conditions in
perinatal period
Service delivery ecosystem 8. Proportion of women with access to mental health services during
the perinatal period
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
Service delivery ecosystem 9. Proportion of healthcare providers trained to provide mental
healthcare in perinatal period
113
114
115 The purpose of this paper is to present the process for developing a set of primary and secondary
116 indicators for countries in monitor PMH, discuss challenges in implementation of screening methods and
117 training providers, and provide policy recommendations for integrating perinatal mental health indicators
118 into existing monitoring frameworks.
119 Methods
120 The development of a set of indicators for perinatal mental health involved a multi-stage process to ensure
121 robustness and inclusivity of all World Health Organization (WHO) regions. This was a four-phase
122 process (Table 2) guided by a WHO working group of experts and included online surveys based on the
123 identified indicators of the scoping review and in consultation with the WHO Mother and Newborn
124 Information for Tracking Outcomes and Results (MoNITOR) advisory group. This process brought to the
125 finalization of global indicators on PMH with primary and secondary indicators for further reflection and
126 adjustment.
127 Table 2. Phases to develop global PMH indicators
Phase 1
Establishment of WHO
experts group on PMH
monitoring and discussion
on identified indicators of
the scoping review
Phase 2
First survey with WHO experts
group on PMH monitoring
Phase 3:
Second survey with WHO
experts group on PMH
monitoring and additional
suggested stakeholders from
global, regional and country
level
Phase 4:
Consultation with WHO experts
group on PMH monitoring and
the WHO MoNITOR advisory
group and development of global
PMH indicators
128
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
129
130 In phase one, a WHO working group of experts, comprised of 21 experts in perinatal mental health and
131 monitoring and evaluation, from diverse regional backgrounds, was convened to provide guidance on
132 indicator selection. The role of the WHO working group included providing feedback on the scoping
133 review, on the list of proposed indicators and relevance in relation to the ToC; feedback and review on the
134 findings from surveys, and of the proposed indicators, including feasibility of implementation.
135 In phases two and three, two rounds of surveys were conducted through an anonymized online form,
136 among an international group of stakeholders, including healthcare professionals, researchers,
137 policymakers, and representatives from civil society organizations. In phase two with the first survey,
138 respondents were asked to select the top three PMH indicators for global monitoring from the list of nine
139 indicators identified through the previous scoping review [17] and to propose any additional indicators
140 used at the country-level which may be useful for global monitoring. During phase three the second
141 survey included a wider group of stakeholders invited to order the list of indicators, selected from the
142 previous survey, from the most to the least important indicator; and to propose additional ones if relevant.
143 After each round of survey, the WHO working group of experts had online consultations to provide
144 feedback on the findings. The specific questions of the two surveys are reported in S1 First and second
145 surveys.
146
147 The first survey was completed by 21 members of the WHO working group, resulting in a total of 17
148 answers out of 21 participants. The second survey was completed by 35 stakeholders part of a broader
149 group of experts involved more generally in maternal, newborn, child and adolescent health program
150 implementation, mental health programme and monitoring and evaluation from global, regional and
151 country levels. These stakeholders were identified through WHO regional offices and by the members of
152 the WHO expert committee. The second survey requested participants to In the second survey the first
153 question collected a total of 17 answers, while the second questions collected 8 answers.
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
154 Phase four included consultation with the WHO experts group on PMH monitoring and the WHO
155 MoNITOR advisory group and development of global PMH indicators. Firstly, the feedback obtained
156 from these surveys was analysed and a list of proposed indicators was developed to ensure their relevance
157 and applicability across different settings. Later on, the WHO Mother and Newborn Information for
158 Tracking Outcomes and Results (MoNITOR) advisory group and the WHO experts group on PMH
159 monitoring, shared overall guidance and inputs on the results collected from the two surveys, which
160 further informed the development process.
161 Inclusion and exclusion criteria were established to ensure the selection of indicators that met predefined
162 quality standards and objectives. Indicators were included if they demonstrated validity, reliability,
163 feasibility and potential impact for advocacy purposes. They also needed to be relevant to the assessment
164 of perinatal mental health conditions and be able to measure progress towards improving maternal and
165 newborn health outcomes for global monitoring purposes. Indicators were excluded if they lacked
166 empirical evidence, were risk-related to develop PMH conditions or were overly complex or resource-
167 intensive or were specific to a particular context and not generalizable to a broader population.
168
169 This work is based on the review of the literature and expert opinion, including WHO’s technical
170 advisory groups on monitoring and measurement, and it is not original research. Therefore, we did not
171 seek approval from the WHO ERC for ethical clearance.
172 We obtained written consent from members of the WHO expert group, following WHO protocols for
173 expert group participation, which include declarations of interest and confidentiality agreements. The
174 consent forms are securely stored on WHO servers, protected by a password. The WHO expert group has
175 been involved in this activity on the prioritization of the PMH indicators from the 8th of December 2023
176 until the 25th of April 2024.
177
178 Results
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
179 A summary of all steps in the selection of the indicators and results on the identification and prioritization
180 of indicators can be found in S2 Table.
181 Results from phase two (first survey)
182 A total of 17 out of 21 WHO Working Group members selected the top three PMH indicators for global
183 monitoring choosing from the nine indicators identified through the previous scoping review [17] (Table
184 3).
185 Table 3. The PMH indicators for global monitoring in order of relevance by stakeholders from the
186 first survey
Theory of change
domain
Indicator Score
Service delivery
ecosystem
7. Proportion of women screened for mental health
conditions in perinatal period
12 (70%)
Service delivery
ecosystem
8. Proportion of women with access to mental health
services during the perinatal period
12 (70%)
Service delivery
ecosystem
9. Proportion of healthcare providers trained to provide
mental healthcare in perinatal period
11 (64%)
187
188 Additionally, three more indicators have been suggested to be important for inclusion (although not
189 classified as top three) which are at individual level: 2. “Proportion of women with depression in perinatal
190 period”; 6. “Proportion of women with mental health conditions in perinatal period” and 1. “Proportion of
191 women with postpartum depression”.
192 Nine respondents proposed additional indicators used at the country-level potentially useful for global
193 monitoring:
194 Postnatal care (PNC) disaggregated for women and baby
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
195 Early Childhood Development Index (ECDI)
196 System readiness indicators: 1. Presence of content on screening and counseling for maternal
197 mental health in relevant pre-service curricula (MCH nurses; Community Health Workers etc.); 2.
198 Antenatal care (ANC) and postnatal care (PNC) consultation /home visit guidelines including
199 PMH screening, counseling & follow up
200 Availability of PMH policy or included in national mental health policy
201 PMH included in WHO country annual work plan
202 PMH included in national health policy and other documents
203 Proportion of health budget (mental health budget) allocated to maternal mental health (I have not
204 used, but would be a useful indicator of high-level commitment at governance level)
205
206 Results from phase three (second survey)
207 The survey requested 35 participants to put in order from the most important to the least the priority PMH
208 indicators for global monitoring identified in the previous survey by the WHO working group of experts
209 and to propose any additional indicator.
210 17 stakeholders completed the survey and the most voted indicators have been listed in order of priority:
211 1. Proportion of women with access to mental health services during the perinatal period;
212 2. Proportion of women screened for mental health conditions in perinatal period
213 3. Proportion of healthcare providers trained to provide mental healthcare in perinatal period;
214 4. Proportion of women with mental health conditions in perinatal period;
215 5. Proportion of women with depression in perinatal period
216 6. Proportion of women with postpartum depression
217 Additionally, eight respondents suggested the inclusion of additional indicators such as:
218 Proportion of women with perinatal mental condition linked to psychosocial support OR mental
219 health services
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
220 Proportion of health budget allocated to perinatal mental health
221 The proportion of women attending a first referral appointment for treatment of a mental health
222 condition
223 Women with anxiety during perinatal period and additional risk-related indicators for PMH
224
225 Results from phase four
226 Results consultations with WHO expert committee
227 Following analysis of both surveys results, the key recommendations by the WHO expert committee were
228 on the identification and prioritisation of indicators and on feasibility and implementation. These two
229 aspects will be described separately.
230 Identification and prioritisation of indicators
231 There was consensus from the WHO expert group to include the list of indicators below based on
232 prioritisation from stakeholders and likely feasibility:
233 To include indicators number 1. “Proportion of women with postpartum depression” and 2.
234 “Proportion of women with depression in perinatal period” , which are important although may
235 be difficult to measure initially.
236 To include indicator 6. “Proportion of women with mental health conditions in perinatal period”,
237 and to better describe the common mental health conditions in the metadata.
238 The committee also discussed the inclusion of indicator 7. “Proportion of women screened for
239 mental health conditions in perinatal period” versus the possible inclusion of an indicator which
240 measured the number of consultations on PMH through ANC and PNC services. It was decided to
241 include indicator 7 since will already provide more specific information with the use of validated
242 screening tools. Further, the WHO recommendations on maternal and newborn care for a positive
243 postnatal experience currently include PMH services for PNC [20] but not for ANC [21],
244 therefore different countries could have a different approach in providing PMH services.
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
245 To include indicator 9. “Proportion of healthcare providers trained to provide mental healthcare in
246 perinatal period”.
247 Then a list the indicators that were excluded (and rationale):
248 To exclude indicator 8. “Proportion of women with access to mental health services during the
249 perinatal period”. This indicator was excluded because of the unclear definition of “access”, and
250 reliable measurement at a national level was considered less feasible.
251 To exclude an indicator which measures anxiety during pregnancy although this can contribute to
252 postpartum depression. The expert group acknowledged anxiety as an important issue in PMH
253 and a precursor to and as a risk factor for depression. Since we were specifically excluding
254 indicators of risk factors, this indicator has been excluded.
255
256 Additional new indicators that were added:
257 The WHO expert committee recognized the importance of having two indicators for advocacy
258 purposes on budget allocation and on existing national policies for PMH. If countries are unable
259 to identify the budget specifically for PMH, the budget allocated to mental health may be reported
260 instead
261 To group some indicators as health system indicators: budget, trained staff, etc... Suggested
262 grouping indicators by primary indicators to monitor from the start and additional secondary
263 indicators to monitor within a later timeframe.
264 Feasibility and implementation
265 To include the data source for each indicator to assist with prioritization. It was agreed to focus
266 on a few indicators, define their purpose, and use them to advocate for services. It was recognised
267 that PMH services may not be well defined, or even existent in many countries.
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
268 To include recommendations consistently on screening tools to use for data collection, and where
269 to locate resources and services at national level. Although screening is not universal, each
270 country should have adopted a specific tool at national level.
271
272 Results from consultation with WHO MoNITOR advisory group
273 The consultation with WHO MoNITOR advisory group was focused on the feasibility and
274 implementation of the global PMH indicators. They identified the need to refine the indicators related to
275 perinatal mental health services, as well as the training and competencies required by healthcare providers
276 in order to offer mental healthcare services during the perinatal period. It was also deemed essential to
277 identify the specific mental health conditions that need to be measured and provide clear definitions for
278 these conditions. Additionally, there should be a specification of the screening tools approved by WHO,
279 along with the appropriate timeframe for their use. Clarification is needed on how and where to measure
280 these indicators, along with considerations for ethical practices in the measurement process. The inclusion
281 of referral processes and psychosocial support within the mental health services needs to be detailed. It is
282 important to harmonize WHO guidelines by including perinatal mental health recommendations in
283 guidelines on childbirth and antenatal care.
284 Given the variety of information to be collected and possible weaknesses in routine data collection
285 systems, indicators could be collected by different sources. Some of the indicators could be integrated
286 into HIMS or collected through national reporting (e.g. for indicators concerning existence of a national
287 PMH policy, government expenditure, health providers trained), while others may be more reliably
288 collected through national surveys like DHS or MICS or mental heath surveys (e.g. indicators on
289 population prevalence of perinatal depression).
290 There should be a clear outline of the key elements required in a national plan for perinatal mental health,
291 such as the tools to use, the planning period, training, and the types of services available. The risk of
292 underreporting must be acknowledged. The indicator on the proportion of women with postpartum
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
293 depression should be retained, as postpartum conditions are among the most frequently diagnosed.
294 Finally, there should be specific screening for perinatal mental health conditions for women staying in the
295 hospital for their small and sick newborns in NICUs.
296
297 Indicators for perinatal mental health monitoring
298 Based on the consultations a list of primary indicators and a list of secondary indicators was created based
299 on capacity or quality data available (Table 4 and Table 5). Metadata providing more detailed
300 descriptions of each indicator is available in S3 File.
301 Table 4. Primary indicators for global monitoring
Monitoring
domain
Indicator Numerator Denominator Current
preferred
data source
Other
data
sources
Output Proportion of
countries with
national policy /plan
for perinatal mental
health in
SRMNCAH or in
the mental health
policy/strategy
Number of
countries with
national
policy for
perinatal
mental health
in
SRMNCAH
policy/strategy
or in the
mental health
policy/strategy
Total number
of countries
Policy review
or WHO
Policy survey
Proportion of
women screened for
mental health
conditions in
perinatal period 1
Number of
women who
were screened
for mental
health
conditions in
in perinatal
period 1
Total number
of women
who gave
birth within a
given time
period
Household
surveys
RHISOutcome
Proportion of
women with
depression in
perinatal period1
Number of
women
identified with
depression2 in
the perinatal
period1
Total number
of women
who gave
birth within a
given time
period
Household
survey
RHIS
302
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
303 Table 5. Secondary indicators for global monitoring
Monitoring
domain
Indicator Numerator Denominator Current
preferred
data source
Other
data
sources
Proportion of government
allocated expenditure to
perinatal mental health
Total
government
allocated
expenditure
to perinatal
mental
health
Total
government
allocated
expenditure
on health3
Output
Proportion of in-service
health care providers
trained to provide mental
healthcare services4 in
perinatal period
Number of
in-service
health care
providers
trained to
provide
mental
healthcare
services in
perinatal
period
Total number
of in-service
health care
providers
providing
services in
perinatal
period
Health facility
assessment
NHAs
Outcome Proportion of women with
perinatal mental health
condition linked to
psychosocial support OR
mental health services
Number of
women with
perinatal
mental
health
condition
linked to
psychosocial
support OR
mental
health
services
Total number
of women
with perinatal
mental health
condition
Household
survey
RHIS
304
305 1 Perinatal period: during pregnancy and up to 1 year after pregnancy
306 2 Depression following consultation and use of available screening tool
307 3 Relatively crude indicator
308 4 Mental Healthcare services include a variety of interventions, and it is not limited to screening of mental health conditions.
309 Please refer to the WHO Guide for integration of perinatal mental health in maternal and child health services. Geneva: World
310 Health Organization; 2022.
311
312 The primary indicators proposed for perinatal mental health monitoring represent measures aimed at
313 capturing key aspects of maternal psychological wellbeing during pregnancy and up to one year
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
314 postpartum. These indicators have been carefully selected based on their significance in assessing the
315 population prevalence, policy and health system plans related to perinatal mental health conditions. They
316 serve as foundational metrics for monitoring PMH conditions and policies aimed at improving maternal
317 and newborn health outcomes. Primary indicators include measures in individual and healthcare system
318 domains, such as the prevalence of antenatal and postnatal depression, rates of screening coverage for
319 perinatal mental health conditions in the perinatal period, and the proportion of countries with national
320 policy or plan for perinatal mental health.
321
322 In addition to the primary indicators, secondary indicators are proposed to guide future efforts and
323 advancements in perinatal mental health monitoring within a later timeframe. These secondary indicators
324 represent desired outcomes and areas for improvement that may require additional research, resources,
325 and policy initiatives to achieve. They encompass measures aimed at enhancing the comprehensiveness,
326 accuracy, and equity of perinatal mental health monitoring, as well as addressing emerging challenges and
327 priorities in the field. Secondary indicators include individual, health service delivery and healthcare
328 system domains, assessing the proportion of women receiving timely and appropriate treatment for
329 perinatal mental health conditions, the proportion of in-service health care providers trained to provide
330 mental healthcare services, and the budget expenditure allocated to improve this population issue.
331 By setting ambitious yet achievable goals for the future, secondary indicators pave the way for continued
332 progress and innovation in perinatal mental health monitoring and ultimately contribute to better
333 outcomes for women and newborns worldwide.
334 Discussion
335 The proposed global PMH indicators has significant implications for global monitoring efforts at global
336 and national levels. By establishing a standardized set of metrics, countries can systematically track and
337 compare the prevalence and outcomes of perinatal mental health conditions across regions and over time.
338 This allows for more accurate assessment of the burden of perinatal mental health disorders and
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
339 identification of populations at greatest risk. Additionally, standardized indicators facilitate the evaluation
340 of interventions and policies aimed at improving maternal and newborn health outcomes, enabling
341 countries to identify effective strategies and allocate resources more efficiently. Moreover, by raising
342 awareness and prioritizing perinatal mental health on the global agenda, the proposed indicators can
343 catalyze action and advocacy to address this critical public health issue. The WHO expert committee’s
344 advised to choose indicators to reflect key dimensions of perinatal mental health including prevalence,
345 screening, policy and health system plans related to perinatal mental health. Priority was given to
346 indicators that were evidence-based, feasible to measure, and relevant to global monitoring efforts.
347 Consideration was also given to indicators that could be easily integrated into existing health information
348 systems and data collection tools as the ones used by hospital and households’ surveys to facilitate
349 implementation and sustainability.
350
351 Challenges in implementing standardized monitoring systems
352 The need to strengthen coordination and technical leadership to harmonize recommendations for
353 improved measurement and monitoring of data related to maternal and newborn heath has been
354 highlighted in previous publications [17, 18] and by the WHO MoNITOR Advisory group [22]. Despite
355 the potential benefits, implementing standardized monitoring systems for maternal and newborn health
356 and in this case for perinatal mental health specifically, poses several challenges. These include resource
357 constraints, particularly in low- and middle-income countries, where healthcare infrastructure, funding,
358 coverage and poor accessibility of PMH services may limit data collection. The integration of PMH into
359 maternal and newborn health services including validated screening and diagnostic tools would be
360 essential in the implementation of a monitoring system [23].
361 There are also technical challenges related to data collection, reporting mechanisms, the quality of data,
362 and interoperability of health information systems which hamper disparities in monitoring efforts between
363 high-income and low-income countries [24]. The national routine health information system is essential
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
364 for decision-making, providing regular data on delivery and utilization of services and can be used for
365 program planning and track progress towards national and subnational targets [25]. In an effort to include
366 new indicators as the ones proposed in this paper, it is important to consider the use of household and
367 health facility survey. Household surveys are the primary source of coverage data for LMICs [26],
368 however not all interventions suggested by this framework can feasibly be tracked using this method.
369 Linking household and facility surveys would improve the coverage measurement, linking care-seeking
370 data from household surveys with service provision data from health facility assessments provides a
371 unique opportunity to produce measures of population coverage that account for service quality [27].
372 These indicators offer the opportunity to be integrated into the next version of DHS or MICS.
373 Additionally, cultural and contextual factors may influence the acceptability and uptake of standardized
374 monitoring protocols, requiring tailored approaches to implementation. Addressing these gaps is essential
375 for improving the accuracy, comprehensiveness, and equity of perinatal mental health monitoring
376 worldwide and requires sustained commitment from governments, healthcare providers, and international
377 partners, as well as investment in capacity building and health system strengthening. Starting with
378 primary indicators to then expand to secondary indicators would enable each national system to build
379 capacity and advocate for an improved monitoring system in this area.
380
381 Opportunities for collaboration and capacity building for healthcare
382 workers
383 Collaboration and capacity building are essential for the successful implementation of standardized
384 monitoring systems for perinatal mental health. Multisectoral collaboration involving government
385 agencies, healthcare providers, academia, civil society organizations, and international partners can
386 leverage expertise and resources to support monitoring efforts [28]. Capacity building initiatives,
387 including task sharing and group problem solving therapy can empower health workers and users with the
388 knowledge and skills needed to respond, screen, diagnose, treat or refer to another specialist, perinatal
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
389 mental health conditions effectively [29, 30]. This includes training on culturally sensitive approaches to
390 care, evidence-based interventions, and integration of mental health services into routine antenatal and
391 postnatal care [23]. By fostering collaboration and investing in capacity building, countries can strengthen
392 their healthcare systems and improve outcomes for women and newborns.
393
394 Policy recommendations for integrating perinatal mental health
395 indicators into existing monitoring frameworks
396 Integrating perinatal mental health indicators into existing monitoring frameworks requires policy
397 support and coordination at the national and international levels. Policymakers should integrate primary
398 and secondary PMH indicators into existing health information systems and monitoring frameworks for
399 maternal and newborn health, ensuring data on maternal psychological wellbeing are routinely collected
400 and reported. Additionally, policies should prioritize funding for mental health services and workforce
401 development, ensuring that healthcare providers have the resources and support needed to address
402 perinatal mental health effectively [31]. Finally, policies should promote collaboration across sectors and
403 encourage the adoption of evidence-based practices to improve perinatal mental health outcomes. By
404 incorporating perinatal mental health indicators into existing monitoring frameworks. Countries can
405 enhance their capacity to address this critical public health issue and achieve better outcomes for women
406 and newborns.
407 The proposed global indicators for perinatal mental health encompass a range of measures aimed at
408 capturing key aspects of maternal psychological wellbeing during pregnancy and the postpartum period.
409 By tracking these indicators, we can better understand the burden of perinatal mental health conditions,
410 identify gaps in care, and assess the effectiveness of interventions. Ultimately, these indicators have the
411 potential to improve maternal and newborn health outcomes by informing policy and practice and guiding
412 resource allocation to areas of greatest need. Additionally, pilot testing of these global PMH indicators to
413 finalize a PMH monitoring framework in different settings is needed to help identify any practical
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
414 challenges or limitations, conduct data validation, and allow for further refinement and optimization
415 before full-scale implementation.
416 Conclusion
417 Given the significant impact of perinatal mental health on maternal and newborn health outcomes, there is
418 an urgent need for global stakeholders to prioritize the provision and monitoring of perinatal mental
419 health care. This includes governments, international organizations, healthcare providers, researchers, and
420 civil society organizations. Global stakeholders are called upon to pilot the global PMH indicators into
421 existing monitoring frameworks and programs, allocating resources for mental health services, and
422 promoting collaboration and capacity building among healthcare workers. By working together to address
423 perinatal mental health, we can ensure that all women receive the support and care they need to thrive
424 during pregnancy and the postnatal period, ultimately leading to better outcomes for both women and
425 newborns.
426
427 Acknowledgements
428 We acknowledge the kind contribution of each member of the WHO expert group on PMH monitoring
429 and the WHO MoNITOR advisory group.
430
431 References
432 1. The Lancet. Perinatal depression: a neglected aspect of maternal health. Lancet. 2023;402(10403):667
433 2. World Organization WH. WHO guide for integration of perinatal mental health in maternal and child health services.
434 Geneva; 2022.
435 3. WHO. ICD 11 Reference Guide. Geneva; 2019
436 4. Howard LM, Molyneaux E, Dennis C-L, Rochat T, Stein A, Milgrom J. Non-psychotic mental disorders in the
437 perinatal period. The Lancet. 2014;384(9956):1775-88.
438 5. Jones I, Chandra PS, Dazzan P, Howard LM. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and
439 the post-partum period. The Lancet. 2014;384(9956):1789-99
440 6. Manolova G, Waqas A, Chowdhary N, Salisbury TT, Dua T. Integrating perinatal mental healthcare into maternal and
441 perinatal services in low and middle income countries. BMJ. 2023;381:e073343.
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
442 7. World Health Organization. Maternal mental health n.d. [Available from: https://www.who.int/teams/mental-health-
443 and-substance-use/promotion-prevention/maternal-mental-health
444 8. Herba CM, Glover V, Ramchandani PG, Rondon MB. Maternal depression and mental health in early childhood: an
445 examination of underlying mechanisms in low-income and middle-income countries. Lancet Psychiatry.
446 2016;3(10):983-92.
447 9. Roddy Mitchell A, Gordon H, Lindquist A, Walker SP, Homer CSE, Middleton A, et al. Prevalence of Perinatal
448 Depression in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2023
449 10. Wang Z, Liu J, Shuai H, Cai Z, Fu X, Liu Y, Xiao X, Zhang W, Krabbendam E, Liu S, Liu Z, Li Z, Yang BX.
450 Correction: Mapping global prevalence of depression among postpartum women. Transl Psychiatry. 2021 Dec
451 20;11(1):640. doi: 10.1038/s41398-021-01692-1. Erratum for: Transl Psychiatry. 2021 Oct 20;11(1):543. doi:
452 10.1038/s41398-021-01663-6. PMID: 34930896; PMCID: PMC8688482.
453 11. Gelaye B, Rondon MB, Araya R, Williams MA. Epidemiology of maternal depression, risk factors, and child outcomes
454 in low-income and middle-income countries. Lancet Psychiatry. 2016;3(10):973-82.
455 12. McNab S DS, Gomez P, Bhatti A, Khadka N, Kenyi E. The Silent Burden: Common Perinatal Mental Disorders in
456 Low- and Middle-Income Countries. Washington, DC.: USAID MOMENTUM.; 2021.
457 13. Stein A, Pearson RM, Goodman SH, Rapa E, Rahman A, McCallum M, et al. Effects of perinatal mental disorders on
458 the fetus and child. Lancet. 2014;384 North American Edition (9956):1800-19.
459 14. Molenaar JM, Boesveld IC, Kiefte-de Jong JC, Struijs JN. Monitoring the Dutch Solid Start Program: Developing an
460 Indicator Set for Municipalities to Monitor their First Thousand Days-Approach. International journal of integrated
461 care. 2022;22(4):8
462 15. Centers for Disease Control and Prevention Chronic Disease Indicators U.S. Department of Health and Human
463 Services; 2023 [Available from: https://www.cdc.gov/cdi/.
464 16. Meneses Navarro S, Serván-Mori E, Heredia-Pi I, Pelcastre B, Nigenda G. Ethnic Disparities in Sexual and
465 Reproductive Health in Mexico After 25 Years of Social Policies. Sexuality Research and Social Policy. 2022;19:1-16.
466 17. Layton E., Mitchell A.R., Kennedy E., Moran A.C., Palestra F., Chowdhary N., McNab S., Homer C.S.E., Maternal
467 Mental Health Matters: A scoping review of indicators for perinatal mental health, Plos- to be confirmed
468 18. McNab SE, Fitzgerald L, Stalls S, Bhatti AM, Doggett E, Ricca J, et al. A Shared Vision for Improving Perinatal
469 Mental Health in Low- and Middle-Income Countries: A Theory of Change and Prioritized Implementation Research
470 Questions. USAID, MOMENTUM; 2022.
471 19. Mental health atlas 2020. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
472 20. WHO recommendations on maternal and newborn care for a positive postnatal experience. Geneva: World Health
473 Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO
474 21. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organization;
475 2016.
476 22. Moller AB, Newby H, Hanson C, Morgan A, El Arifeen S, Chou D, Diaz T, Say L, Askew I, Moran AC. Measures
477 matter: A scoping review of maternal and newborn indicators. PLoS One. 2018 Oct 9;13(10):e0204763. doi:
478 10.1371/journal.pone.0204763. PMID: 30300361; PMCID: PMC6177145.
479 23. Manolova G, Waqas A, Chowdhary N, Salisbury TT, Dua T. Integrating perinatal mental healthcare into maternal and
480 perinatal services in low and middle income countries. BMJ. 2023 May 23;381:e073343. doi: 10.1136/bmj-2022-
481 073343. PMID: 37220917; PMCID: PMC10203867.
482 24. Kabue MM, Palestra F, Katwan E, Moran AC. Availability of priority maternal and newborn health indicators: Cross-
483 sectional analysis of pregnancy, childbirth and postnatal care registers from 21 countries. PLOS Glob Public Health.
484 2023 Jan 5;3(1):e0000739. doi: 10.1371/journal.pgph.0000739. PMID: 36962773; PMCID: PMC10021477.
485 25. Mallick L, Temsah G, Namaste S, Dontamsetti T, and Wang W. Using Health Management Information Systems Data
486 to Contextualize Survey-based Estimates of Fertility, Mortality, and Wasting: DHS Occasional Paper; No. 12. ICF;
487 Rockville, Maryland, USA: 2020. Available from: https://dhsprogram.com/pubs/pdf/OP12/OP12.pdf. [Google Scholar]
488 26. Munos MK, Stanton CK, Bryce J, Core Group for Improving Coverage Measurement for MNCH Improving coverage
489 measurement for reproductive, maternal, neonatal and child health: gaps and opportunities. J Glob Health.
490 2017;7:010801. doi: 10.7189/jogh.07.010801
491 27. Kanyangarara M, Chou VB, Creanga AA, Walker N. Linking household and health facility surveys to assess obstetric
492 service availability, readiness and coverage: evidence from 17 low- and middle-income countries. J Glob Health. 2018
493 Jun;8(1):010603. doi: 10.7189/jogh.08.010603. PMID: 29862026; PMCID: PMC5963736.
494 28. Ng’oma M, Bitew T, Kaiyo-Utete M, Hanlon C, Honikman S, Stewart RC. Perinatal mental health around the world:
495 priorities for research and service development in Africa. BJPsych International. 2020;17(3):56-59.
496 doi:10.1192/bji.2020.16
497 29. J E M Nakku, O Nalwadda, E Garman, S Honikman, C Hanlon, F Kigozi, C Lund. Group problem solving therapy for
498 perinatal depression in primary health care settings in rural Uganda: an intervention cohort study (2021), BMC
499 Pregnancy and Childbirth 21:584. DOI: 10.1186/s12884-021-04043-6
500 30. S Boisits, Z Abrahams, M Schneider, S Honikman, D Kaminer and C Lund. Developing a task-sharing psychological
501 intervention to treat mild to moderate symptoms of perinatal depression and anxiety in South Africa: a mixed-method
502 formative study (2021), Int J Ment Health Syst15, 23. DOI: 10.1186/s13033-021-00443-5
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
OFFICIAL
503 31. Schiller CE, Cohen MJ, O'Hara MW. Perinatal mental health around the world: priorities for research and service
504 development in the USA. BJPsych Int. 2020 Nov;17(4):87-91. doi: 10.1192/bji.2020.15. PMID: 33196694; PMCID:
505 PMC7609989.
506
507
508
509
510
511
for use under a CC0 license.
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprintthis version posted October 6, 2024. ; https://doi.org/10.1101/2024.10.04.24314919doi: medRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.